Cefoxitin Side Effects
Brand Names: Mefoxin
Please note - some side effects for Cefoxitin may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects of Cefoxitin - for the Consumer
Cefoxitin
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome when using Cefoxitin:
Seek medical attention right away if any of these SEVERE side effects occur when using Cefoxitin:Diarrhea; nausea; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody stools; decreased urination; dizziness; fever; hoarseness; pain, swelling, or redness at the injection site; red, swollen, or blistered skin; seizures; severe diarrhea; severe nausea or vomiting; stomach pain or cramping; unusual bruising or bleeding; unusual tiredness; vaginal irritation or discharge; vein inflammation; white patches in mouth; yellowing of the eyes and skin.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
TopCefoxitin Side Effects - for the Professional
Cefoxitin
Cefoxitin for Injection is generally well tolerated. The most common adverse reactions have been local reactions following intravenous injection. Other adverse reactions have been encountered infrequently.
Local Reactions
Thrombophlebitis has occurred with intravenous administration.
Allergic Reactions
Rash (including exfoliative dermatitis and toxic epidermal necrolysis), urticaria, flushing, pruritus, eosinophilia, fever, dyspnea, and other allergic reactions including anaphylaxis, interstitial nephritis and angioedema have been noted.
Cardiovascular
Hypotension.
Gastrointestinal
Diarrhea, including documented pseudomembranous colitis which can appear during or after antibiotic treatment. Nausea and vomiting have been reported rarely.
Neuromuscular
Possible exacerbation of myasthenia gravis
Blood
Eosinophilia, leukopenia including granulocytopenia, neutropenia, anemia, including hemolytic anemia, thrombocytopenia, and bone marrow depression. A positive direct Coombs test may develop in some individuals, especially those with azotemia.
Liver Function
Transient elevations in SGOT, SGPT, serum LDH, and serum alkaline phosphatase; and jaundice have been reported.
Renal Function
Elevations in serum creatinine and/or blood urea nitrogen levels have been observed. As with the cephalosporins, acute renal failure has been reported rarely. The role of Cefoxitin for Injection in changes in renal function tests is difficult to assess, since factors predisposing to prerenal azotemia or to impaired renal function usually have been present.
In addition to the adverse reactions listed above which have been observed in patients treated with Cefoxitin for Injection, the following adverse reactions and altered laboratory test results have been reported for cephalosporin class antibiotics:
Urticaria, erythema multiforme, Stevens-Johnson syndrome, serum sickness-like reactions, abdominal pain, colitis, renal dysfunction, toxic nephropathy, false-positive test for urinary glucose, hepatic dysfunction including cholestasis, elevated bilirubin, aplastic anemia, hemorrhage, prolonged prothrombin time, pancytopenia, agranulocytosis, superinfection, vaginitis including vaginal candidiasis.
Several cephalosporins have been implicated in triggering seizures, particularly in patients with renal impairment when the dosage was not reduced. If seizures associated with drug therapy occur, the drug should be discontinued. Anticonvulsant therapy can be given if clinically indicated.
TopSide Effects by Body System - for Healthcare Professionals
General
Cefoxitin is generally well-tolerated.
Hypersensitivity
Hypersensitivity reactions have included pruritus, rash, exfoliative dermatitis, toxic epidermal necrolysis, urticaria, flushing, dyspnea, angioedema, anaphylaxis, interstitial nephritis, eosinophilia, and fever. Cephalosporin class antibiotics have been associated with erythema multiforme, Stevens-Johnson syndrome, and serum sickness-like reactions.
There is a 10% to 20% chance of an allergic reaction to cefoxitin (or any cephalosporin) among patients who are allergic to a penicillin.
A case of occupational contact dermatitis due to cephalosporin allergy has been reported in a nurse who prepared cephalosporin solutions for administration to patients. The dermatitis resolved after the nurse stopped preparing the solutions.
Gastrointestinal
Gastrointestinal side effects have included nausea, vomiting, diarrhea, and pseudomembranous colitis. Cephalosporin class antibiotics have been associated with abdominal pain and colitis.
A 60-year-old man with bilateral staghorn renal calculi, Proteus mirabilis urinary tract infection, and acute renal failure developed non-bloody diarrhea and fever associated with leukocytosis and ileus within two days after beginning cefoxitin 1 gram intravenously once a day. Sigmoidoscopy and stool pathology revealed innumerable small white plaques and Clostridium difficile toxin. The cefoxitin was stopped, vancomycin retention enemas were given (due to ileus, oral vancomycin was not tried), and the patient recovered.
A study of 374 patients demonstrated that of 21 patients developing Clostridium difficile colitis, 17.9% had received cefoxitin.
Pseudomembranous colitis may occur during or after treatment.
Nervous system
Nervous system side effects have included somnolence, dizziness, and headache. Some cephalosporin-class antibiotics have been associated with seizures, especially in patients with renal dysfunction.
Renal
Renal side effects have included increased serum creatinine and blood urea nitrogen, and acute renal failure (rare). Cephalosporin class antibiotics have been associated with renal dysfunction, toxic nephropathy, reversible, dose-related acute tubular necrosis, and interstitial nephritis. Interstitial nephritis manifests as reversible fever, azotemia, pyuria, and eosinophiluria.
Local
Local side effects have included thrombophlebitis with intravenous administration.
Cardiovascular
Cardiovascular side effects have included hypotension.
Musculoskeletal
Musculoskeletal side effects have included exacerbation of myasthenia gravis.
Hematologic
Hematologic side effects have included eosinophilia, leukopenia, granulocytopenia, neutropenia, anemia, hemolytic anemia, thrombocytopenia, bone marrow depression, and positive direct Coombs' test. Cephalosporin class antibiotics have been associated with aplastic anemia, hemorrhage, prolonged prothrombin time, pancytopenia, and agranulocytosis.
Hepatic
Hepatic side effects have included transient elevations of SGOT, SGPT, LDH, and alkaline phosphatase, and jaundice. Cephalosporin class antibiotics have been associated with hepatic dysfunction, cholestasis, and elevated bilirubin.
Genitourinary
Genitourinary side effects associated with cephalosporin class antibiotics have included vaginitis, vaginal candidiasis, and false positive tests for urine glucose.
Other
Other side effects associated with cephalosporin class antibiotics have included superinfection.
Other
Other side effects associated with higher doses of cefoxitin have included an increased incidence of SGOT elevations and eosinophilia in pediatric patients.
TopMore Cefoxitin resources
- cefoxitin Concise Consumer Information (Cerner Multum)
- cefoxitin Intravenous Advanced Consumer (Micromedex) - Includes Dosage Information
- Cefoxitin Prescribing Information (FDA)
- Cefoxitin MedFacts Consumer Leaflet (Wolters Kluwer)
- Cefoxitin Sodium Monograph (AHFS DI)
- Mefoxin Prescribing Information (FDA)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
